Dados B3 › Restatements
Has PROFARMA DISTRIB PROD FARMACEUTICOS S.A. (PFRM3) ever restated its financial statements? In which years?
Yes: the statements for 2010, 2012, 2013, 2019, 2021, 2024 came back with different figures in the following year's annual filing — 20 account(s) in all, each below with both values.
| Year | Account | As first filed | As restated | Difference | Revealed in (CVM file) |
|---|---|---|---|---|---|
| 2010 | transactions with shareholders (DMPL 5.04) | R$ -861 k | R$ 133 k | 115.4% | DFP 2011 · 26/03/2013 |
| 2010 | income taxes (DRE 3.08) | R$ -6.3 m | R$ -4.4 m | 29.2% | DFP 2011 · 26/03/2013 |
| 2010 | profit before taxes (DRE 3.07) | R$ 40.6 m | R$ 34.5 m | 15.2% | DFP 2011 · 26/03/2013 |
| 2010 | net income plus OCI (DMPL 5.05) | R$ 34.4 m | R$ 30.0 m | 12.7% | DFP 2011 · 26/03/2013 |
| 2010 | profit in the statement of changes in equity (DMPL 5.05.01) | R$ 34.4 m | R$ 30.0 m | 12.7% | DFP 2011 · 26/03/2013 |
| 2010 | profit from continuing operations (DRE 3.09) | R$ 34.4 m | R$ 30.0 m | 12.7% | DFP 2011 · 26/03/2013 |
| 2010 | net profit (DRE 3.11) | R$ 34.4 m | R$ 30.0 m | 12.7% | DFP 2011 · 26/03/2013 |
| 2010 | profit attributable to controlling shareholders (DRE 3.11.01) | R$ 34.4 m | R$ 30.0 m | 12.7% | DFP 2011 · 26/03/2013 |
| 2010 | operating profit (EBIT) (DRE 3.05) | R$ 69.9 m | R$ 63.7 m | 8.8% | DFP 2011 · 26/03/2013 |
| 2010 | equity (BPP 2.03) | R$ 518.9 m | R$ 508.4 m | 2.0% | DFP 2011 · 26/03/2013 |
| 2010 | closing equity (DMPL 5.07) | R$ 518.9 m | R$ 508.4 m | 2.0% | DFP 2011 · 26/03/2013 |
| 2010 | opening equity (DMPL 5.03) | R$ 485.4 m | R$ 478.2 m | 1.5% | DFP 2011 · 26/03/2013 |
| 2010 | current liabilities (BPP 2.01) | R$ 438.5 m | R$ 440.7 m | 0.5% | DFP 2011 · 26/03/2013 |
| 2012 | cost of goods and services (DRE 3.02) | R$ -3.60 bn | R$ -3.03 bn | 15.8% | DFP 2013 · 31/03/2014 |
| 2012 | net revenue (DRE 3.01) | R$ 3.80 bn | R$ 3.23 bn | 15.0% | DFP 2013 · 31/03/2014 |
| 2013 | gross profit (DRE 3.03) | R$ 231.2 m | R$ 350.4 m | 34.0% | DFP 2014 · 29/06/2018 |
| 2013 | cost of goods and services (DRE 3.02) | R$ -2.85 bn | R$ -2.73 bn | 4.2% | DFP 2014 · 29/06/2018 |
| 2019 | net operating cash flow (DFC_MI 6.01) | R$ 126.9 m | R$ 127.6 m | 0.5% | DFP 2020 · 16/03/2021 |
| 2021 | net income plus OCI (DMPL 5.05) | R$ 72.9 m | R$ 67.7 m | 7.2% | DFP 2022 · 17/10/2023 |
| 2024 | net operating cash flow (DFC_MI 6.01) | R$ 302.0 m | R$ 326.7 m | 7.6% | DFP 2025 · 27/03/2026 |
How it is detected: each year appears twice at the CVM — in its own annual filing and as the comparative in the next one. A difference above 0.5% in a key account is recorded, never corrected silently. Only the aggregation the site publishes (consolidated, or individual when the company does not consolidate) counts. Descriptive, not investment advice.
PFRM3 — company page · all restatements in the base
Numbers on this page are live. Data version 2026-09-24-salto-de-acoes · page generated 2026-09-26 23:57 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-24-salto-de-acoes · page generated 2026-09-26 23:57 UTC. If this does not match /saude, you are reading a cached copy.